BioRap and BioTheryX Sign Strategic Collaborative Agreement for the Development of Novel Protein Degradation Compounds for the Treatment of Cancer and Immune Disorder

2021-05-19T16:05:48-07:00September 8, 2016|

CHAPPAQUA, N.Y., Sept. 08, 2006 /PRNewswire/ -- BioTheryX, Inc. (BTX), is developing next-generation drugs that selectively regulate the stability of [...]